Nephrotic Syndrome: all 197 studies
Page 2 of 2. Open to participants first (65), then studies with results posted, then the rest; newest registration first within each.
- Causes and Prevention of Thromboembolic Disease in Nephrotic SyndromeCompletedNCT04850378Phase 1/2
- Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic SyndromeCompletedNCT04818723Not applicable
- Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic SyndromeCompletedNCT04783675Phase 2
- Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic SyndromeStatus unknownNCT04713410Not applicable
- Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome.Status unknownNCT04585152Phase 2
- Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.TerminatedNCT04558892Phase 2/3
- Study of Initial Steroid Treatment in Young Children With Nephrotic SyndromeWithdrawnNCT04536181Phase 3
- Randomized Trial Evaluating Mycophenolate Mofetil in Children With Nephrotic Syndrome After Rituximab TreatmentWithdrawnNCT04531865Phase 3
- Rituximab for Idiopathic Nephrotic SyndromeCompletedNCT04494438Phase 3
- Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic SyndromeTerminatedNCT04402580Phase 2
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseTerminatedNCT04387448Phase 2
- Thyroid Dysfunction in Patients With Nephrotic SyndromeStatus unknownNCT04323007Not applicable
- Non-invasive Assessment of Mechano-chemical Properties of Urine Proteins by Hybrid Brillouin-Raman SpectroscopyStatus unknownNCT04311684
- A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic SyndromeCompletedNCT04278729Phase 1
- Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic SyndromeCompletedNCT04169776Not applicable
- Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic SyndromeCompletedNCT04048161Phase 4
- Population Pharmacokinetics of Tacrolimus in Nephrotic SyndromeStatus unknownNCT04045171
- Reduce Immunosuppression With Atmp in NS ChildrEnCompletedNCT04034316Phase 2
- RItuximab From the FIRst Episode of Idiopathic Nephrotic SyndromeStatus unknownNCT03970577Phase 2
- Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic SyndromeCompletedNCT03899103Phase 3
- Steroid Sensitive Nephrotic Syndrome in ChildrenTerminatedNCT03878914Phase 4
- Personalized Medicine for Membranous NephropathyCompletedNCT03804359Phase 2
- CHILDNEPH The Canadian Childhood Nephrotic Syndrome StudyStatus unknownNCT03786263
- Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic SyndromeStatus unknownNCT03750136Not applicable
- Experience With H.P. Acthar Gel Treatment of Patients With Nephrotic Syndrome/Proteinuria Due to Various Etiologies and Its Effect on Podocyte FunctionStatus unknownNCT03644771
- Diagnostic and Prognostic Value of Miss-1 Study in Children and Adult With Nephrotic Syndrome MISSNEPHROTIQUEStatus unknownNCT03592030
- Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic SyndromeSuspendedNCT03560011Phase 2/3
- ACTHAR Gel for Drug REsistant Nephrotic Syndrome in ChildrenWithdrawnNCT03408405Phase 4
- Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive BiomarkerCompletedNCT03387176
- Pharmacokinetics of Tacrolimus in ChildrenCompletedNCT03347357Phase 4
- The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic SyndromeCompletedNCT03332420
- Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle EastStatus unknownNCT03326037
- Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic SyndromeStatus unknownNCT03298698Phase 3
- Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic SyndromeStatus unknownNCT03235128
- Cyclosporin A Therapy in Childhood Nephrotic SyndromeStatus unknownNCT03219684
- Active Vitamin D and Reduced Dose Prednisolone for Treatment in Minimal Change NephropathyCompletedNCT03210688Phase 4
- Prednisolone Trial in Children Younger Than 4 YearsCompletedNCT03141970Phase 3
- Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)Status unknownNCT03062813Phase 4
- Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic SyndromeSuspendedNCT03042637
- Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic SyndromeTerminatedNCT03004001Phase 2
- Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot StudyWithdrawnNCT02997150Phase 2
- Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)Status unknownNCT02966717Phase 2
- Valproic Acid for Idiopathic Nephrotic SyndromeStatus unknownNCT02896270Phase 2/3
- Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in ChildrenCompletedNCT02818738Phase 3
- Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic SyndromeStatus unknownNCT02649413Phase 4
- Study of Tacrolimus Used for Pediatric Patients With Nephrotic Syndrome Based on Pharmacogenomics and MetabonomicsStatus unknownNCT02602873
- Pharmacokinetics of Apixaban in Nephrotic SyndromeCompletedNCT02599532Phase 1
- IL-2 for Multi Drug Resistant Nephrotic SyndromeCompletedNCT02455908Phase 1/2
- Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic SyndromeCompletedNCT02438982Phase 3
- Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic EdemaCompletedNCT02427880Phase 4
- Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic SyndromeCompletedNCT02394119Phase 2
- Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic SyndromeTerminatedNCT02394106Phase 2
- Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)Status unknownNCT02382874Phase 1
- Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic SyndromeStatus unknownNCT02382575Phase 4
- Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational StudyCompletedNCT02298335Not applicable
- A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic SyndromeCompletedNCT02257697Phase 3
- Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.CompletedNCT02238418Phase 4
- Low Dose Steroids in the Treatment of Nephrotic Syndrome RelapseStatus unknownNCT02216747Phase 4
- Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureActive, not recruitingNCT02194582
- Assessment of the Educational Experiences for Patients Newly Diagnosed With Nephrotic SyndromeCompletedNCT02190955
- Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic SyndromeCompletedNCT01895894Phase 4
- Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic SyndromeCompletedNCT01845428Phase 1
- A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeCompletedNCT01763580Phase 4
- Rituximab Trial for Pediatric Nephrotic SyndromeStatus unknownNCT01716442Phase 2/3
- Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence StudyCompletedNCT01663129
- Pharmacokinetics of Cyclosporin in Nephrotic SyndromeCompletedNCT01616446
- Factors of Steroid Dependency in Idiopathic Nephrotic SyndromeCompletedNCT01609426
- Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric PatientsCompletedNCT01447485Phase 1
- Role of PACAP in Nehprotic SyndromeCompletedNCT01411982
- Steroid Treatment of Idiopathic Nephrotic SyndromeCompletedNCT01386957
- Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic SyndromeStatus unknownNCT01346007Phase 4
- The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)CompletedNCT01309477Phase 3
- Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During ChildhoodCompletedNCT01268033Phase 2/3
- Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated DiseasesCompletedNCT01252901
- Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic SyndromeCompletedNCT01197040Phase 3
- Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized StudyCompletedNCT01185197Phase 4
- Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney DiseaseCompletedNCT01156428
- Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in ChildrenCompletedNCT01092962Phase 3
- Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)CompletedNCT01028287Phase 4
- Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic SyndromesCompletedNCT01021540Phase 4
- The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous NephropathyCompletedNCT00983034Not applicable
- Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)CompletedNCT00981838Phase 3
- Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental GlomerulosclerosisTerminatedNCT00883636
- Fluid Balance, Hormones and Urine Proteomics in Nephrotic Syndrome in ChildhoodCompletedNCT00690586
- Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)CompletedNCT00615667Phase 3
- Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic SyndromeCompletedNCT00577525
- Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic SyndromeCompletedNCT00362531Phase 2/3
- Efficacy of Pentoxifylline on Primary Nephrotic SyndromeCompletedNCT00354731Phase 3
- Long Term Tapering or Standard Steroids for Nephrotic SyndromeStatus unknownNCT00308321Phase 4
- Glucocorticoid-induced Osteopenia in ChildrenCompletedNCT00289328
- Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic SyndromeCompletedNCT00286910
- Kidney Disease BiomarkersCompletedNCT00255398
- Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic SyndromeCompletedNCT00172276
- Study of the Safety and Efficacy of NC-503 in Secondary (AA) AmyloidosisCompletedNCT00035334Phase 2/3
- Once-A-Month Steroid Treatment for Patients With Focal Segmental GlomerulosclerosisCompletedNCT00004990Phase 2
- Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic SyndromeTerminatedNCT00004466Phase 2
- Drug Therapy in Lupus NephropathyCompletedNCT00001212Phase 2